乳晕边缘切口及压力封闭残腔技术在乳腺良性肿块切除术中的应用  

Clinical Application of Periareolar Incision and Pressure Closure of Residual Cavity Technology in the Resection of Benign Breast Lump

作　　者：闫建平[1] 连红霞[1] 李秀刚[1] 

机构地区：[1]呼和浩特市第一医院肿瘤科,内蒙古呼和浩特010000

出　　处：《中外医疗》2016年第25期86-87,90,共3页China & Foreign Medical Treatment

摘　　要：目的探讨在乳腺良性肿块切除术中应用乳晕边缘切口及压力封闭残腔技术的疗效。方法方便选取80例于2013年4月—2014年4月期间在该院行局部手术的乳腺良性肿块患者,根据残腔处理的不同分为缝闭腺体残腔组(A组)和压力封闭残腔组(B组),均行乳腺良性肿块切除术,观察两组临床疗效、满意度、乳房外形变化率及术后1、2d时VAS评分情况。结果两组切口愈合率差异无统计学意义,但B组满意度较A组显著要高(P<0.05),分别为97.5%、82.5%,而乳房外形变化率显著低于A组(P<0.05),分别为2.5%、15.0%;同时两组术后1、2 d时VAS评分比较差异无统计学意义(P>0.05),术后3 d时B组VAS评分显著低于A组(P<0.05),分别为(2.13±0.35)分、(2.62±0.39)分,差异均有统计学意义。结论在乳腺良性肿块切除术中应用乳晕边缘切口及压力封闭残腔技术可取得显著疗效,具有推广价值。Objective To study the clinical effect of periareolar incision and pressure closure of residual cavity technology in the resection of benign breast lump. Methods Convenient selection 80 patients with benign breast lump treated from April 2013 to April 2014 in our hospital were divided into two groups according to the different processing method of residual cavity.Group A adopted the sewing of residual cavity;Group B adopted the pressure closure of residual cavity. The benign breast lump was resected. The clinical effect, satisfaction, breast shape and VAS point after 1 d and 2 d of surgery for two groups was observed. Results The healing rate of the incision for two groups was not significantly different;the satisfaction of Group B（97.5%） was higher than that of Group A（82.5%）（P〈0.05）;the bad rate of breast shape for Group B（2.5%） was lower than that of Group A（15.0%）（P〈0.05）;After 1 d and 2 d of surgery,the VAS point for two groups was not significantly different（P〉0.05）; after 3 d of surgery,the VAS point for Group B and Group A was（2.13 ±0.35）poimts and（2.62 ±0.39）poimts（P〈0.05）.Conclusion During the resection of benign breast lump, the periareolar incision and pressure closure of residual cavity technology has an obvious effect in clinical practice. It is worthy of promotion.

关 键 词：压力封闭残腔技术 乳晕边缘切口 乳腺良性肿块切除术 

分 类 号：R73[医药卫生—肿瘤]